AGAM
IBB icon

Audent Global Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Audent Global Asset Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.56M Sell
15,185
-9,432
-38% -$1.61M 2.56% 15
2025
Q4 		$4.15M Buy
24,617
+2,231
+10% +$362K 2.63% 12
2025
Q3 		$3.23M Sell
22,386
-3,223
-13% -$440K 2.35% 18
2025
Q2 		$3.24M Buy
25,609
+57
+0.2% +$7K 2.31% 16
2025
Q1 		$3.27M Sell
25,552
-1,892
-7% -$257K 2.7% 14
2024
Q4 		$3.63M Buy
27,444
+18,800
+217% +$2.64M 2.36% 15
2024
Q3 		$1.26M Sell
8,644
-585
-6% -$84.6K 2.15% 18
2024
Q2 		$1.27M Sell
9,229
-1,865
-17% -$249K 1.32% 22
2024
Q1 		$1.52M Buy
11,094
+3,728
+51% +$509K 1.56% 22
2023
Q4 		$1M Sell
7,366
-6,584
-47% -$803K 1.18% 31
2023
Q3 		$1.71M Buy
13,950
+1,429
+11% +$182K 1.23% 22
2023
Q2 		$1.59M Buy
12,521
+5,818
+87% +$756K 1.33% 23
2023
Q1 		$866K Buy
6,703
+4,705
+235% +$616K 1.21% 27
2022
Q4 		$262K Sell
1,998
-353
-15% -$45.6K 0.45% 35
2022
Q3 		$275K Buy
2,351
+240
+11% +$29.8K 0.37% 39
2022
Q2 		$248K Sell
2,111
-1,310
-38% -$156K 0.17% 43
2022
Q1 		$446K Sell
3,421
-49,971
-94% -$6.51M 0.24% 43
2021
Q4 		$8.15M Buy
+53,392
New +$8.27M 3.41% 12

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Audent Global Asset Management's IBB Position: Q1 2026 in Review

Audent Global Asset Management reduced its iShares Biotechnology ETF (IBB) stake by 38% in Q1 2026, selling an estimated $1.61M and leaving 15,185 shares worth $2.56M. The position accounts for 2.56% of the portfolio, ranked #15.

Audent Global Asset Management first reported a position in IBB in Q4 2021 and has held it in 18 quarters since. The position peaked at $8.15M in Q4 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Audent Global Asset Management held 15,185 shares of iShares Biotechnology ETF worth $2.56M as of Q1 2026.
  • Audent Global Asset Management sold 9,432 iShares Biotechnology ETF shares in Q1 2026, an estimated $1.61M.
  • iShares Biotechnology ETF made up 2.56% of Audent Global Asset Management's portfolio in Q1 2026, its #15 holding.
  • Audent Global Asset Management first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 18 quarters since.
  • Audent Global Asset Management's iShares Biotechnology ETF position peaked at $8.15M in Q4 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Audent Global Asset Management's 13F filing for Q1 2026, filed 6 May 2026.